![Ralph Spillner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ralph Spillner
Direktor/Vorstandsmitglied bei Cyprotex Discovery Ltd.
Profil
Ralph Enno Spillner is currently a Director at Cyprotex Discovery Ltd., Evotec (UK) Ltd., and Aptuit (Oxford) Ltd.
He previously served as a Director at Cyprotex Ltd.
and held the position of Managing Director at Evotec (.
Hamburg) GmbH.
Aktive Positionen von Ralph Spillner
Unternehmen | Position | Beginn |
---|---|---|
Cyprotex Discovery Ltd.
![]() Cyprotex Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Cyprotex Discovery Ltd. is a British company that specializes in in vitro toxicology studies using a range of techniques such as cell-based assays, mass spectrometer, fluorescence imaging, and qrt-pcr endpoints. The company is based in Abingdon, UK. The company also offers mitochondrial toxicity assays including seahorse assay, glu/gal assay, mitochondrial biogenesis, mitochondrial membrane potential, and mitochondrial mass. | Direktor/Vorstandsmitglied | - |
Evotec (UK) Ltd.
![]() Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The company is based in Abingdon, UK and was founded in 1991. | Direktor/Vorstandsmitglied | 18.07.2016 |
Aptuit (Oxford) Ltd.
![]() Aptuit (Oxford) Ltd. Pharmaceuticals: MajorHealth Technology Part of Evotec SE, Aptuit (Oxford) Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Abingdon, UK. | Direktor/Vorstandsmitglied | 11.08.2017 |
Ehemalige bekannte Positionen von Ralph Spillner
Unternehmen | Position | Ende |
---|---|---|
CYPROTEX PLC | Direktor/Vorstandsmitglied | 28.03.2023 |
Evotec (Hamburg) GmbH
![]() Evotec (Hamburg) GmbH Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (Hamburg) GmbH provides companies with administration and management services. The company is based in Hamburg, Germany. The CEO of the German company is Ralph Enno Spillner. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Cyprotex Discovery Ltd.
![]() Cyprotex Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Cyprotex Discovery Ltd. is a British company that specializes in in vitro toxicology studies using a range of techniques such as cell-based assays, mass spectrometer, fluorescence imaging, and qrt-pcr endpoints. The company is based in Abingdon, UK. The company also offers mitochondrial toxicity assays including seahorse assay, glu/gal assay, mitochondrial biogenesis, mitochondrial membrane potential, and mitochondrial mass. | Commercial Services |
Evotec (UK) Ltd.
![]() Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The company is based in Abingdon, UK and was founded in 1991. | Commercial Services |
Aptuit (Oxford) Ltd.
![]() Aptuit (Oxford) Ltd. Pharmaceuticals: MajorHealth Technology Part of Evotec SE, Aptuit (Oxford) Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Abingdon, UK. | Health Technology |
Evotec (Hamburg) GmbH
![]() Evotec (Hamburg) GmbH Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (Hamburg) GmbH provides companies with administration and management services. The company is based in Hamburg, Germany. The CEO of the German company is Ralph Enno Spillner. | Commercial Services |
Cyprotex Ltd.
![]() Cyprotex Ltd. Miscellaneous Commercial ServicesCommercial Services Cyprotex Ltd. provides pharmaceutical research and development services. It offers ADME and pharmacokinetic, Biosciences, in vitro skin and ocular testing, physicochemical profiling, in vitro toxicology, in silico prediction, and endocrine disruption. The company was founded by David Leahy in 1999 and is headquartered in Abingdon, the United Kingdom. | Commercial Services |